Nicholas S. Green
2022
In 2022, Nicholas S. Green earned a total compensation of $6.2M as President and Chief Executive Officer at Peregrine Pharmaceuticals, a 117% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $895,200 |
|---|---|
| Salary | $600,000 |
| Stock Awards | $4,642,450 |
| Other | $44,174 |
| Total | $6,181,824 |
Green received $4.6M in stock awards, accounting for 75% of the total pay in 2022.
Green also received $895.2K in non-equity incentive plan, $600K in salary and $44.2K in other compensation.
Rankings
In 2022, Nicholas S. Green's compensation ranked 482nd out of 5,387 executives tracked by ExecPay. In other words, Green earned more than 91.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 482 out of 5,387 | 91st |
Division Manufacturing | 198 out of 2,922 | 93rd |
Major group Chemicals And Allied Products | 54 out of 1,304 | 96th |
Industry group Drugs | 42 out of 1,209 | 97th |
Industry Pharmaceutical Preparations | 28 out of 870 | 97th |
Source: SEC filing on August 29, 2022.
Green's colleagues
We found two more compensation records of executives who worked with Nicholas S. Green at Peregrine Pharmaceuticals in 2022.